(Q35547607)

8 August 2017

Mortality and causes of death in a Swedish series of systemic sclerosis patients (English)

1 reference

8 August 2017

0 references

Hesselstrand R

1

1 reference

8 August 2017

Scheja A

series ordinal

2

1 reference

8 August 2017

Akesson A

series ordinal

3

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 November 1998

1 reference

Annals of the Rheumatic Diseases

8 August 2017

1 reference

8 August 2017

57

1 reference

8 August 2017

11

1 reference

8 August 2017

682-686

1 reference

Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population.

8 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752504

Mortality in systemic sclerosis: a comparison with the general population.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752504

Scleroderma and malignancy: an epidemiological study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752504

Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752504

Systemic sclerosis in Iceland. A nationwide epidemiological study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752504

Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year followup study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752504

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752504

Survival with scleroderma—II: A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752504

Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752504

Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752504

Scleroderma and scleroderma-like disorders

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752504

Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752504

Progressive systemic sclerosis: mode of presentation, rapidly progressive disease course, and mortality based on an analysis of 91 patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752504

Mortality from scleroderma in England and Wales 1968-1985

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752504

Initial predictors of survival in patients with systemic sclerosis (scleroderma)

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752504

A study of scleroderma in South Australia: prevalence, subset characteristics and nailfold capillaroscopy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752504

Cancer in systemic sclerosis

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752504

Suicide as an outcome for medical disorders

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752504

Long-term follow-up study of 164 patients with definite systemic sclerosis: classification considerations

26 September 2018

1 reference

12 December 2020

Mortality in systemic sclerosis (scleroderma)

1 reference

12 December 2020

Predictors of survival in systemic sclerosis (scleroderma)

1 reference

12 December 2020

Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between the CREST syndrome and diffuse scleroderma

1 reference

12 December 2020

Cardiac involvement in systemic sclerosis

1 reference

12 December 2020

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis

1 reference

12 December 2020

A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): the value of a simple cutaneous classification in the early stages of the disease

1 reference

12 December 2020

Plasmapheresis and immunosuppressive drug therapy in scleroderma

1 reference

12 December 2020

Cancer in families with systemic sclerosis

1 reference

12 December 2020

Limited scleroderma is associated with increased prevalence of macrovascular disease

1 reference

12 December 2020

Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis

1 reference

12 December 2020

Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease

1 reference

12 December 2020

Survival analysis of 118 patients with systemic sclerosis

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.57.11.682

1 reference

8 August 2017

1 reference

8 August 2017

1 reference